SynthesisFrontiers in oncology2020

Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR) Inhibitors Plus Antiangiogenic Agents as First-Line Treatments for Patients With Advanced

Fei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.